Back to Search
Start Over
Thryv Therapeutics to Present Results of Wave I Part 1 Clinical Study at American College of Cardiology Conference in Atlanta, Georgia on April 7th, 2024
- Source :
- Plus Company Updates. March 28, 2024
- Publication Year :
- 2024
-
Abstract
- MONTREAL: Thryv Therapeutics Inc. has issued the following news release: Thryv Therapeutics is pleased to announce the presentation of its poster: SGK1 inhibitor LQT-1213 significantly attenuates dofetilide-induced QT prolongation in [...]
- Subjects :
- Cardiology
Clinical trials
Dofetilide
General interest
News, opinion and commentary
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.788171471